Press release
Ovarian Cancer Market Research Report 2022, Global Industry Trends, Size, Share, Value, Covied 19 Impact And Forecast Till 2027 | IMARC Group
๐๐ฅ๐จ๐๐๐ฅ ๐๐ฏ๐๐ซ๐ข๐๐ง ๐๐๐ง๐๐๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ (๐๐๐๐-๐๐๐๐)
โข Historical Market Size (2021):US$ 1.68 Billion
โข Forecast CAGR (2022-2027):11.40%
โข Forecast Market Size (2027): US$ 3.34 Billion
๐๐ฆ๐ฉ๐๐๐ญ ๐จ๐ ๐๐๐๐๐-๐๐:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ :
https://www.imarcgroup.com/ovarian-cancer-market/requestsample
๐๐ก๐๐ญ ๐ข๐ฌ ๐ ๐๐ฏ๐๐ซ๐ข๐๐ง ๐๐๐ง๐๐๐ซ ๐๐๐ซ๐ค๐๐ญ ?
Ovarian cancer is caused by the abnormal growth of cells in the ovaries that begin to multiply and grow uncontrollably from the outer tissue lining or fallopian tubes due to mutagenic changes in the deoxyribonucleic acid (DNA).
Some commonly known ovarian cancers are epithelial ovarian carcinomas, germ cell tumors, stromal cell tumors, and ovarian sarcoma. They are treated with chemotherapy, surgery, immunotherapy, radiation, and targeted therapies that help kill cancer cells and relieve signs and symptoms.
These therapeutics are performed by medical practitioners after determining multiple factors, such as the spread of the tumor, the individual's general health, and the size and type of ovarian cancer. As a result, ovarian cancer treatment is widely adopted across hospitals and specialty centers.
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐ฆ๐๐ฃ๐จ๐ซ ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐ฏ๐๐ซ๐ข๐๐ง ๐๐๐ง๐๐๐ซ ๐๐๐ซ๐ค๐๐ญ ?
The market is primarily driven by the increasing prevalence of ovarian cancer. This can be attributed to the family history of ovarian cancer, inhabitation of gene mutation (BRCA1 or BRCA2), lynch syndrome amongst the female geriatric population, obesity, and endometriosis.
In addition, the widespread adoption of combination therapies in the healthcare industry to prevent drug resistance and increase treatment efficacy is contributing to market growth.
Moreover, various initiatives undertaken by non-governmental organizations (NGOs) to sensitize consumers concerning the symptoms, treatments, and benefits of early ovarian cancer diagnosis represent another major growth-inducing factor.
Besides this, the market is further propelled by the extensive investment in cancer research worldwide.
Moreover, with the ongoing patent expiration of branded medications, pharmaceutical companies are introducing novel recombinant drugs.
This, coupled with the extensive research and development (R&D) activities to produce efficient therapeutic interventions and strategic collaborations amongst key players, is creating a positive market outlook across the globe.
๐๐ฌ๐ค ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ญ ๐๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐ฎ๐ฅ๐ฅ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐ & ๐๐ข๐ฌ๐ญ ๐จ๐ ๐ ๐ข๐ ๐ฎ๐ซ๐:
https://www.imarcgroup.com/ovarian-cancer-market
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
The report has been segmented the market into following categories:
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ ๐๐ฒ๐ฉ๐:
o Epithelial Ovarian Cancer
o Germ Cell Ovarian Cancer
o Stromal Cell Ovarian Cancer
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐ฒ๐ฉ๐:
o Immunotherapy
o Chemotherapy
o Targeted Therapy
o Surgery
o Others
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ง๐ ๐๐ฌ๐๐ซ:
o Hospitals
o Homecare
o Specialty Centre
o Others
๐๐ฒ ๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ฒ:
โข North America (United States, Canada)
โข Europe (Germany, France, United Kingdom,
Italy, Spain, Others)
โข Asia Pacific (China, Japan, India, Australia,
Indonesia, Korea, Others)
โข Latin America (Brazil, Mexico, Others)
โข Middle East and Africa (United Arab Emirates,
Saudi Arabia, Qatar, Iraq, Other)
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฃ๐จ๐ซ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
โข AbbVie Inc.
โข Amneal Pharmaceuticals Inc.
โข AstraZeneca plc, Eli Lilly and Company
โข F. Hoffmann-La Roche AG, GSK plc
โข Hikma Pharmaceuticals PLC
โข Lupin Limited, Pfizer Inc.
โข and Teva Pharmaceutical Industries Ltd.
๐๐๐ฒ ๐ก๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ:
โข Market Performance (2016-2021)
โข Market Outlook (2022- 2027)
โข Porter's Five Forces Analysis
โข Market Drivers and Success Factors
โข SWOT Analysis
โข Value Chain
โข Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐ญ๐ก๐๐ซ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ-
hair conditioner market Report 2022-2027-
https://www.marketwatch.com/press-release/hair-conditioner-market-size-share-expected-growth-and-industry-forecast-2022-2027-imarc-group-2022-12-02
Military Transport Aircraft Market Size 2022-2027
https://www.marketwatch.com/press-release/global-military-transport-aircraft-market-size-share-analysis-and-industry-forecast-2022-2027-imarc-group-2022-12-02
Hydrogel Dressing Market Size 2022-2027-
https://www.marketwatch.com/press-release/hydrogel-dressing-market-size-share-scope-industry-analysis-and-forecast-2022-2022-imarc-group-2022-12-02
Nucleotides Market Forecast 2022-2027-
https://www.marketwatch.com/press-release/nucleotides-global-market-size-share-report-forecast-period-2022-2027-imarc-group-2022-12-02
Artificial Vital Organs and Medical Bionics Market Size 2022-2027
https://www.marketwatch.com/press-release/artificial-vital-organs-and-medical-bionics-market-size-industry-analysis-top-countries-data-major-manufacturers-and-forecast-2027-2022-11-30
Behavioral Mental Health Care Software Market Share 2022-2027-
https://www.marketwatch.com/press-release/behavioralmental-health-care-software-market-size-2022-value-industry-growth-covied-19-impact-and-forecast-till-2027-by-product-application-end-users-region-imarc-group-2022-11-30
๐๐ผ๐ป๐๐ฎ๐ฐ๐ ๐จ๐:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
๐๐ฏ๐ผ๐๐ ๐จ๐:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ovarian Cancer Market Research Report 2022, Global Industry Trends, Size, Share, Value, Covied 19 Impact And Forecast Till 2027 | IMARC Group here
News-ID: 2835028 • Views: โฆ
More Releases from IMARC Group
Australia Financial Services Market 2025 | Worth USD 317.7 Billion to 2025-2033
Market Overview
The Australia financial services market size reached USD 201.3 Billion in 2024 and is projected to grow to USD 317.7 Billion by 2033. The market is expected to expand steadily with a compound annual growth rate of 5.2% during the forecast period from 2025 to 2033. Key factors driving this growth include the rising demand for digital banking, regulatory advancements, strong economic performance, increasing fintech investments, and enhanced consumerโฆ
Australia Advanced Carbon Dioxide Sensors Market | Worth USD 103.89 Million 2026 โฆ
Market Overview
The Australia advanced carbon dioxide sensors market size was USD 59.19 Million in 2025 and is expected to grow to USD 103.89 Million by 2034. The market growth is driven by strong government-led emissions reduction policies, enhanced building standards for CO2 monitoring, and the integration of IoT-enabled sensor technologies in smart buildings. These trends are supported by increased focus on indoor air quality and workplace health, fueling innovation inโฆ
Australia Used Car Market Projected to Reach USD 197 Billion by 2033
Market Overview
The Australia used car market was valued at USD 77.2 Billion in 2024 and is projected to reach USD 197 Billion by 2033. The market is experiencing strong growth driven by affordability concerns, rising demand for reliable pre-owned vehicles, and the increasing role of digital platforms that simplify transactions. Economic pressures and the shift toward cost-effective vehicle options are further accelerating expansion, making the used car market a vitalโฆ
Australia Electric Truck Market Projected to Reach USD 133.0 Million by 2033
Market Overview
The Australia electric truck market reached USD 17.1 Million in 2024 and is projected to expand to USD 133.0 Million by 2033. With a forecast period spanning 2025 to 2033, the market is growing significantly due to stringent government emissions regulations, rising fuel costs, and advancements in battery and charging infrastructure technologies. Investments in fleet electrification and sustainable transport solutions are further driving market share growth. For further details,โฆ
More Releases for Ovarian
Ovarian Cancer Diagnostics Market Size: 2033 Statistics
The Ovarian Cancer Diagnostics market is expected to grow from an estimated USD 4814.5 million in 2024 to USD 7795.1 million in 2033, at a CAGR of 5.50%.
The ovarian cancer diagnostics market plays a critical role in the early detection and management of ovarian cancer, one of the most common and lethal gynecological cancers worldwide. Ovarian cancer is often diagnosed at an advanced stage due to the lack of noticeableโฆ
Ovarian Cancer Market Size, Future Trends
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- The global Ovarian Cancer Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players inโฆ
Polycystic Ovarian Syndrome Treatment Market Report
The findings reviewed by GME stated that the Global Polycystic Ovarian Syndrome Treatment Market will expand with a CAGR value of 5.2 percent from 2021 to 2026. The rising incidence of PCOS increased understanding among a group of patients, and the growing acceptance of standard treatment boosts the PCOS treatment industry growth over the projected timeframe. Furthermore, the research and development of PCOS are predicted to aid in market growth.
Browseโฆ
How deadly is Ovarian Cancer?
Ovarian Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
The global Ovarian Cancer Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025,โฆ
Polycystic Ovarian Syndrome Treatment Market - Regional Analysis
The organic and inorganic strategies by the market players will boost the polycystic ovarian syndrome treatment market. For instance, in 2016, Millendo Therapeutics, Inc., a biopharmaceutical company, entered into an exclusive license agreement with AstraZeneca for the development and commercialization of phase II entered AZD4901, a candidate product for the treatment of polycystic ovarian syndrome. Moreover, in 2017, Astellas Pharma Inc. completed its acquisition of Ogeda SA (formerly Euroscreen S.A.).โฆ
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements inโฆ
